Innophos Stock Price, Forecast & Analysis (NASDAQ:IPHS)

Innophos trades on the NASDAQ under the ticker symbol "IPHS."

Innophos announced a quarterly dividend on Tuesday, August 6th. Shareholders of record on Friday, August 23rd will be paid a dividend of $0.48 per share on Friday, September 6th. This represents a $1.92 annualized dividend and a yield of 6.02%. The ex-dividend date is Thursday, August 22nd. View Innophos' Dividend History.

Innophos Holdings, Inc. (NASDAQ:IPHS) released its quarterly earnings data on Wednesday, November, 6th. The specialty chemicals company reported $0.45 earnings per share for the quarter, missing analysts' consensus estimates of $0.55 by $0.10. The specialty chemicals company earned $189 million during the quarter, compared to analysts' expectations of $185.55 million. Innophos had a return on equity of 11.56% and a net margin of 2.82%. The business's revenue was down 4.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.58 earnings per share. View Innophos' Earnings History.

Innophos is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Innophos.

Innophos issued an update on its third quarter 2019 earnings guidance on Monday, October, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $190-190 million, compared to the consensus revenue estimate of $185.55 million.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innophos in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innophos.

News articles about IPHS stock have trended somewhat positive recently, according to InfoTrie. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Innophos earned a coverage optimism score of 2.0 on InfoTrie's scale. They also assigned media coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Innophos.

Innophos saw a drop in short interest in the month of October. As of October 31st, there was short interest totalling 288,200 shares, a drop of 39.2% from the September 30th total of 474,100 shares. Based on an average trading volume of 162,400 shares, the days-to-cover ratio is presently 1.8 days. Currently, 1.5% of the company's stock are short sold. View Innophos' Current Options Chain.

Some companies that are related to Innophos include Ecolab (ECL), Sherwin-Williams (SHW), Celanese (CE), International Flavors & Fragrances (IFF), RPM International (RPM), Albemarle (ALB), NewMarket (NEU), Ashland Global (ASH), W. R. Grace & Co (GRA), Balchem (BCPC), Sensient Technologies (SXT), Quaker Chemical (KWR), HB Fuller (FUL), PolyOne (POL) and Innospec (IOSP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Innophos investors own include Applied Materials (AMAT), Intel (INTC), Energy Transfer LP Unit (ET), Freeport-McMoRan (FCX), 3M (MMM), Costco Wholesale (COST), Cisco Systems (CSCO), FireEye (FEYE), PepsiCo (PEP) and Alibaba Group (BABA).

Innophos' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Confluence Investment Management LLC (0.76%), Foundry Partners LLC (0.69%), Dalton Greiner Hartman Maher & Co. (0.58%), Rhumbline Advisers (0.33%), California Public Employees Retirement System (0.21%) and Synovus Financial Corp (0.08%). View Institutional Ownership Trends for Innophos.

IPHS stock was sold by a variety of institutional investors in the last quarter, including Municipal Employees Retirement System of Michigan and Confluence Investment Management LLC. View Insider Buying and Selling for Innophos.

IPHS stock was purchased by a variety of institutional investors in the last quarter, including Foundry Partners LLC, Dalton Greiner Hartman Maher & Co., California Public Employees Retirement System, Synovus Financial Corp, Russell Investments Group Ltd., State of Alaska Department of Revenue, GW&K Investment Management LLC and HGK Asset Management Inc.. View Insider Buying and Selling for Innophos.

Shares of IPHS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IPHS stock can currently be purchased for approximately $31.90.

Innophos has a market capitalization of $628.14 million and generates $801.84 million in revenue each year. The specialty chemicals company earns $36.07 million in net income (profit) each year or $2.28 on an earnings per share basis. Innophos employs 1,485 workers across the globe.View Additional Information About Innophos.

The official website for Innophos is http://www.innophos.com/.

Innophos' mailing address is 259 PROSPECT PLAINS ROAD, CRANBURY NJ, 08512. The specialty chemicals company can be reached via phone at 609-495-2495 or via email at [email protected]